Sean Wu is an associate in the Shanghai office of Latham & Watkins and a member of the Litigation & Trial Department.

Mr. Wu advises clients on government investigations, internal investigations, due diligence, and compliance programs, in connection with security fraud, fraud, professional standards, FCPA, anti-corruption / anti-bribery, sanctions, and other trade compliance matters in China.  Mr. Wu also advised companies in various cross-border litigations.

Mr. Wu has represented and conducted internal investigations, as well as advised in cross-border litigations, for multinational clients across different industries, including online commence, internet and technology, pharmaceutical, medical, finance, manufacturing, shipping, and consulting.

Prior to joining Latham, Mr. Wu worked in the Beijing office of another leading international law firm.

Mr. Wu’s experience includes:

  • Conducting an internal investigation for the audit committee of a US-listed China-based online commence company into various allegations of potential revenue inflation and representing it before the US Securities and Exchange Commission (SEC)
  • Conducting an internal investigation for a global professional services company’s China offices into whistleblower allegations of potential violations of professional standards and representing it before the SEC and another US regulator
  • Conducting an internal investigation for a Chinese unicorn company in relation to certain related party transactions
  • Conducting an internal investigation for a US-listed manufacturer operating in China into allegations of potential revenue inflation and conflict-of-interest violations 
  • Conducting internal investigations for the audit committee of a US-listed China-based pharmaceutical company, including representing it before the US Department of Justice (DOJ), SEC, and Nasdaq, in connection with potential FCPA violations 
  • Conducting internal investigations for multinational companies, in connection with fraud and anti-bribery matters 
  • Advising COSCO Shipping in connection with the imposition of two subsidiaries on the “SDN” list by the US Department of State and OFAC
  • Conducting internal investigation for a national enterprise on export control and sanctions issues
  • Conducting internal investigation for a multinational energy service provider on export control and sanctions issues
  • Conducting internal investigation for a multinational electronic device manufacturer on export control and sanctions issues
  • Conducting an internal investigation for a multinational finance institute, in connection with export control / financial sanction matters 
  • Conducting an internal investigation for a multinational equipment manufacturer, in connection with trade restriction matters 
  • Conducting an internal investigation for a China-based biopharmaceutical company, in connection with a campaign by certain shareholder to gain board control which involved a defense and litigation strategy
  • Advising a Taiwan-based company in the semiconductor industry to deal with the criminal charges raised by the DOJ on commercial espionage 
  • Performing anti-corruption / anti-bribery compliance due diligence for multinational clients 
  • Advising clients on developing and implementing anti-corruption compliance policies and procedures 
  • Conducting an FCPA investigation for a multinational pharmaceutical company after the Chinese government investigated the company’s violations of PRC anti-bribery laws, including advising the client on disclosures to the DOJ and SEC* 
  • Conducting internal investigations for a multinational technology company’s Asia Pacific and Japan offices, in connection with various matters including conflict of interest, financial fraud, anti-bribery, and other company procedural violations* 
  • Conducting multiple internal investigations for a multinational pharmaceutical company in connection with financial fraud, safety regulation, and anti-bribery matters* 
  • Conducting an internal investigation for a US-listed China-based consulting company in connection with fraud matters*
  • Representing a US-listed medical device company in connection with regulatory inquiries from Chinese and overseas regulators* 

*Matter handled prior to joining Latham

Bar Qualification

  • New York

Education

  • JD, Washington University in St. Louis School of Law
  • Master of Law in Commercial Law, Renmin University of China
  • LL.B in Law, Renmin University of China

Languages Spoken

  • Chinese (Mandarin)
  • English